The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer

Justyna Przybyszewska; Andrzej Kuźmiński; Michał Przybyszewski; Cezary Popławski

doi:10.5114/pg.2024.139209

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

NOWOŚĆ

Portal dla gastroenterologów!

www.egastroenterologia.pl

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

2/2024
vol. 19

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

streszczenie artykułu:

Artykuł przeglądowy

The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer

Justyna Przybyszewska

¹

,

Andrzej Kuźmiński

²

,

Michał Przybyszewski

³

,

Cezary Popławski

¹

Department of Nutrition and Dietetics, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
Department of Allergology, Clinical Immunology, and Internal Diseases, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
Department and Clinic of Allergology, Clinical Immunology, and Internal Diseases, Jan Biziel University Hospital No. 2, Bydgoszcz, Poland

Gastroenterology Rev 2024; 19 (2): 121–126

DOI: https://doi.org/10.5114/pg.2024.139209

Data publikacji online: 2024/04/29

Pełna treść artykułu Pobierz cytowanie

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Przybyszewska J, Kuźmiński A, Przybyszewski M, Popławski C. The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(2):121-126. doi:10.5114/pg.2024.139209.

APA

Przybyszewska, J., Kuźmiński, A., Przybyszewski, M.,  & Popławski, C. (2024). The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(2), 121-126. https://doi.org/10.5114/pg.2024.139209

Chicago

Przybyszewska, Justyna, Andrzej Kuźmiński, Michał Przybyszewski,  and Cezary Popławski. 2024. "The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer". Gastroenterology Review/Przegląd Gastroenterologiczny 19 (2): 121-126. doi:10.5114/pg.2024.139209.

Harvard

Przybyszewska, J., Kuźmiński, A., Przybyszewski, M.,  and Popławski, C. (2024). The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(2), pp.121-126. https://doi.org/10.5114/pg.2024.139209

MLA

Przybyszewska, Justyna et al. "The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 19, no. 2, 2024, pp. 121-126. doi:10.5114/pg.2024.139209.

Vancouver

Przybyszewska J, Kuźmiński A, Przybyszewski M, Popławski C. The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(2):121-126. doi:10.5114/pg.2024.139209.

Metryki PlumX:

Plantago ovata is a common medicinal plant widely cultivated in tropical regions of the world. The outer seed coat of P. ovata, obtained by cleaning the seeds, contains soluble and insoluble fibre in a ratio of 7:3, making products containing P. ovata husk an ideal source of health-beneficial fibre. The results of clinical trials demonstrate the therapeutic efficacy of psyllium husk for various gastrointestinal disorders. It has also been documented that psyllium ingestion exhibits antioxidant, immunomodulatory, antiproliferative, anticancer, and antiviral effects. Such pleiotropic effects of P. ovata husk are related to the presence in its composition of arabinoxylan, which forms a gel in an aqueous environment, as well as bioactive compounds and their metabolites. This article presents the evidence available in the literature on the therapeutic potential and possible mechanisms of action of psyllium in the treatment of irritable bowel syndrome and ulcerative colitis, and prevention of colorectal cancer.

The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer

Justyna Przybyszewska 1 , Andrzej Kuźmiński 2 , Michał Przybyszewski 3 , Cezary Popławski 1

Justyna Przybyszewska

¹

,

Andrzej Kuźmiński

²

,

Michał Przybyszewski

³

,

Cezary Popławski

¹